We are live on ! Find out more
P8IP

Pier 88 Investment Partners Portfolio holdings

AUM $421M
1-Year Est. Return 14.71%
This Fund
S&P 500
This Quarter Est. Return
+15.32%
1 Year Est. Return
+14.71%
3 Year Est. Return
+36.1%
5 Year Est. Return
+43.13%
10 Year Est. Return
–
AUM
$352M
AUM Growth
+$77.8M
Cap. Flow
-$109M
Cap. Flow %
-30.85%
Top 10 Hldgs %
32.55%
Holding
122
New
21
Increased
31
Reduced
23
Closed
11

Top Buys

Rank Stock Value
1
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
+$9.27M
2
SWK icon
Stanley Black & Decker
SWK
+$6.05M
3
AVGOP
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
+$3.91M
4
LSCC icon
Lattice Semiconductor
LSCC
+$1.75M
5
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$1.5M

Top Sells

Rank Stock Value
1
SWP
Stanley Black & Decker, Inc. Corporate Units
SWP
+$5.91M
2
BAC.PRL icon
Bank of America Series L
BAC.PRL
+$4.1M
3
WFC.PRL icon
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
+$4.05M
4
DCUE
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
+$2.99M
5
MODN
MODEL N, INC.
MODN
+$1.35M

Sector Composition

Rank Sector Weight
1 Technology 6.95%
2 Healthcare 4.89%
3 Industrials 3.79%
4 Utilities 3.4%
5 Consumer Discretionary 1.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BYND icon
51
Beyond Meat
BYND
$212M
$968K 0.28%
+7,220
New +$855K
EVOP
52
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$949K 0.27%
41,559
+9,790
+31% +$195K
ECHO
53
DELISTED
Echo Global Logistics, Inc.
ECHO
$944K 0.27%
43,633
+35,518
+438% +$668K
HRTX icon
54
Heron Therapeutics
HRTX
$59.2M
$850K 0.24%
57,826
+12,356
+27% +$203K
FATE icon
55
Fate Therapeutics
FATE
$318M
$827K 0.24%
+24,092
New +$718K
PAGS icon
56
PagSeguro Digital
PAGS
$2.5B
$682K 0.19%
19,310
+1,580
+9% +$44.5K
ADPT icon
57
Adaptive Biotechnologies
ADPT
$4.09B
$625K 0.18%
+12,910
New +$471K
HQY icon
58
HealthEquity
HQY
$8.8B
$625K 0.18%
10,655
-3,880
-27% -$215K
TWST icon
59
Twist Bioscience
TWST
$7.75B
$618K 0.18%
+13,640
New +$489K
BLUE
60
DELISTED
bluebird bio
BLUE
$616K 0.18%
+779
New +$587K
TXG icon
61
10x Genomics
TXG
$7.87B
$600K 0.17%
+6,715
New +$523K
TW icon
62
Tradeweb Markets
TW
$22B
$499K 0.14%
+8,585
New +$494K
PS
63
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$448K 0.13%
24,800
+18,800
+313% +$318K
IOVA icon
64
Iovance Biotherapeutics
IOVA
$2.92B
$308K 0.09%
11,225
+2,035
+22% +$66.9K
MODN
65
DELISTED
MODEL N, INC.
MODN
$264K 0.08%
7,604
-46,175
-86% -$1.35M
NET icon
66
Cloudflare
NET
$111B
$248K 0.07%
+6,910
New +$193K
NEWR
67
DELISTED
New Relic, Inc.
NEWR
$225K 0.06%
3,265
-11,000
-77% -$657K
AYX
68
DELISTED
Alteryx Inc
AYX
$208K 0.06%
1,265
-4,990
-80% -$647K
EEFT icon
69
Euronet Worldwide
EEFT
$2.64B
$206K 0.06%
2,145
-5,895
-73% -$545K
FPI
70
Farmland Partners
FPI
$428M
$202K 0.06%
29,538
-55,637
-65% -$365K
SLAB icon
71
Silicon Laboratories
SLAB
$7.2B
$201K 0.06%
2,001
+400
+25% +$37.4K
TNDM icon
72
Tandem Diabetes Care
TNDM
$1.6B
$173K 0.05%
1,750
-8,520
-83% -$680K
TRHC
73
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$171K 0.05%
3,120
-9,170
-75% -$525K
MTOR
74
DELISTED
MERITOR, Inc.
MTOR
$170K 0.05%
8,600
+3,780
+78% +$69.8K
CYBR
75
DELISTED
CyberArk
CYBR
$133K 0.04%
1,340
-7,700
-85% -$749K
1 2
3
4

Similar funds

SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return
CMHI
CVC Management Holdings II St. Helier, Jersey $420M AUM 0.05% 1-Year Est. Return
MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return
DBRC
D.B. Root & Company Pittsburgh, Pennsylvania $419M AUM 15.03% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
PIMC
Praesidium Investment Management Company New York $419M AUM 4.58% 1-Year Est. Return
VIS
Vega Investment Solutions Paris, France $418M AUM

Pier 88 Investment Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Pier 88 Investment Partners held 122 positions worth $352M, up 28% from $274M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Pier 88 Investment Partners withdrew a net $109M in Q2 2020, closing 11 positions and reducing 23 holdings. Its most notable exit was Stanley Black & Decker, Inc. Corporate Units, an estimated $5.91M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.9% of assets, up from 5.9% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Pier 88 Investment Partners opened a new position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A worth $9.07M.

  • Pier 88 Investment Partners's largest Q2 2020 buy was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A: 86,580 shares worth $9.07M.
  • Pier 88 Investment Partners added most to Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q2 2020, an estimated $3.91M increase.
  • Pier 88 Investment Partners's biggest Q2 2020 reduction was Bank of America Series L, cutting an estimated $4.1M.
  • Pier 88 Investment Partners fully exited Stanley Black & Decker, Inc. Corporate Units in Q2 2020, selling an estimated $5.91M.
  • Pier 88 Investment Partners's ten largest holdings make up 33% of its $352M portfolio in Q2 2020.
  • Pier 88 Investment Partners opened 21 new positions and closed 11 in Q2 2020.
  • Pier 88 Investment Partners's portfolio value rose 28% quarter-over-quarter to $352M.

Based on Pier 88 Investment Partners's 13F filing for Q2 2020, filed 14 Aug 2020.